2015-2019 Future Horizons and Growth Strategies in the Chancroid Testing Market: Supplier Shares and Country Forecasts

August 2015 | 220 pages | ID: 2A74B360D6BEN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chancroid tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.Contains 220 pages and 8 tables

Contents

1. INTRODUCTION

2. CHANCROID WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
E. Emerging Diagnostic Technologies
  1. MOLECULAR DIAGNOSTICS
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. DIFFERENTIAL LIGHT SCATTERING
  5. INFORMATION TECHNOLOGY
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. DIAGNOSTIC IMAGING
  11. GEL MICRODROPLETS
  12. OTHER

3. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

4. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

5. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

6. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

7. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

8. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST Y BY MARKET SEGMENT

9. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

10. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

11. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

12. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Diagnostics Sales by Major Supplier